Association between transjugular intrahepatic portosystemic shunt and sarcopenia in patients with liver cirrhosis
10.3969/j.issn.1001-5256.2023.07.005
- VernacularTitle:肝硬化患者经颈静脉肝内门体分流术与肝硬化肌少症的关系
- Author:
Bin XIONG
1
;
Chongtu YANG
2
Author Information
1. Department of Interventional Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 511407, China
2. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China
- Publication Type:Discussions by Experts
- Keywords:
Liver Cirrhosis;
Portal Hypertension;
Portasystemic Shunt, Transjugular Intrahepatic;
Sarcopenia
- From:
Journal of Clinical Hepatology
2023;39(7):1541-1546
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia is a common complication of liver cirrhosis and is significantly associated with poor prognosis. Transjugular intrahepatic portosystemic shunt (TIPS) is an important method for the treatment of portal hypertension and its complications. Based on current studies, this article analyzes the association between sarcopenia and the outcomes (hepatic encephalopathy and mortality) of patients with liver cirrhosis after TIPS and the value of improving the predictive ability of existing prognostic models for sarcopenia, as well as the improvement in sarcopenia after TIPS and its significance in the clinical management of patients with liver cirrhosis. A comprehensive analysis of existing reports show that baseline sarcopenia is associated with poor prognosis after TIPS, and it is thus recommended to evaluate nutritional status before TIPS based on radiological examination; TIPS can improve nutritional status and help to achieve reversal or improvement of sarcopenia to a certain extent, and it can also be translated into survival benefit. Therefore, for patients with sarcopenia and a relatively stable disease, TIPS can be performed as soon as possible after comprehensive evaluation.
